Healthcare provider profile · identity verified

Robert E Fox, MD

Internal Medicine · WESTERLY, RI · NPI 1003853268

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	321	94
Levothyroxine Sodium	Levothyroxine Sodium	299	75
Losartan Potassium	Losartan Potassium	295	79
Omeprazole	Omeprazole	285	83
Metoprolol Succinate	Metoprolol Succinate	283	69
Alprazolam	Alprazolam	257	61
Lisinopril	Lisinopril	251	65
Amlodipine Besylate	Amlodipine Besylate	243	71
Simvastatin	Simvastatin	236	71
Prednisone	Prednisone	190	59
Gabapentin	Gabapentin	184	43
Trazodone Hcl	Trazodone Hcl	164	43
Rosuvastatin Calcium	Rosuvastatin Calcium	162	42
Metformin Hcl	Metformin Hcl	161	35
Famotidine	Famotidine	141	44
Hydrochlorothiazide	Hydrochlorothiazide	131	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	128	19
Albuterol Sulfate Hfa	Albuterol Sulfate	126	36
Sertraline Hcl	Sertraline Hcl	117	34
Zolpidem Tartrate	Zolpidem Tartrate	117	16
Furosemide	Furosemide	115	36
Clonazepam	Clonazepam	100	13
Metformin Hcl Er	Metformin Hcl	93	20
Meloxicam	Meloxicam	85	25
Eliquis	Apixaban	84	16
Bupropion Xl	Bupropion Hcl	82	23
Pantoprazole Sodium	Pantoprazole Sodium	81	23
Escitalopram Oxalate	Escitalopram Oxalate	79	21
Methylprednisolone	Methylprednisolone	79	52
Ropinirole Hcl	Ropinirole Hcl	79	24
Oxycodone Hcl	Oxycodone Hcl	77	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	76	24
Azithromycin	Azithromycin	75	56
Allopurinol	Allopurinol	74	23
Ozempic	Semaglutide	74	12
Tamsulosin Hcl	Tamsulosin Hcl	74	26
Pravastatin Sodium	Pravastatin Sodium	67	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	62	55
Fluoxetine Hcl	Fluoxetine Hcl	62	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	59	15
Potassium Chloride	Potassium Chloride	56	17
Duloxetine Hcl	Duloxetine Hcl	54	suppressed
Pregabalin	Pregabalin	54	suppressed
Ezetimibe	Ezetimibe	50	14
Lorazepam	Lorazepam	50	12
Olmesartan Medoxomil	Olmesartan Medoxomil	45	13
Venlafaxine Hcl Er	Venlafaxine Hcl	44	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	19
Montelukast Sodium	Montelukast Sodium	43	13
Amoxicillin	Amoxicillin	40	27
Tramadol Hcl	Tramadol Hcl	40	11
Paroxetine Hcl	Paroxetine Hcl	39	12
Atenolol	Atenolol	38	suppressed
Donepezil Hcl	Donepezil Hcl	38	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	38	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	37	suppressed
Diazepam	Diazepam	34	suppressed
Warfarin Sodium	Warfarin Sodium	33	12
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	32	suppressed
Mirtazapine	Mirtazapine	32	suppressed
Myrbetriq	Mirabegron	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	31	28
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	31	25
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	25
Ibuprofen	Ibuprofen	30	13
Glipizide	Glipizide	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Nystatin	Nystatin	20	12
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Celecoxib	Celecoxib	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Glimepiride	Glimepiride	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Clotrimazole	Clotrimazole	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	13
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Ramipril	Ramipril	16	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Estradiol	Estradiol	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Torsemide	Torsemide	13	suppressed
Valsartan	Valsartan	13	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	12	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Klor-Con M10	Potassium Chloride	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Carvedilol	Carvedilol	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Finasteride	Finasteride	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Nystop	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error